TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $7.00 price objective on shares of TRACON Pharmaceuticals in a research note on Monday, November […]

Related Keywords

United States , ,Pharmaceuticals Daily ,Susquehanna International Group ,Pharmaceuticals Inc ,Pharmaceuticals Price Performance ,Ci Private Wealth ,Renaissance Technologies ,Charles Schwab Investment Management Inc ,Free Report ,Get Free Report ,International Group ,Street Group ,Schwab Investment Management ,Tracon Pharmaceuticals ,Nasdaq Tcon ,Ltcon ,Medical ,Initiated Coverage ,Stocknews Com ,